Ye et al. found that CD66b+ tumor-associated neutrophils, Tregs, and CD163+tumor-associated macrophages were significantly correlated with prognosis in CRC patients (Ye et al., 2019). The gene discussed is CEACAM8; the disease is neoplasm.